Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 2
1936 1
1940 1
1946 1
1947 2
1948 3
1950 1
1961 5
1962 2
1963 2
1964 4
1965 2
1966 4
1967 1
1968 2
1969 2
1970 3
1971 2
1972 2
1973 1
1974 3
1975 3
1976 1
1977 4
1978 3
1979 1
1980 1
1981 1
1982 5
1985 4
1986 5
1987 5
1988 10
1989 15
1990 15
1991 19
1992 24
1993 19
1994 29
1995 14
1996 34
1997 23
1998 34
1999 42
2000 46
2001 65
2002 71
2003 93
2004 117
2005 153
2006 174
2007 205
2008 224
2009 282
2010 313
2011 381
2012 407
2013 463
2014 439
2015 476
2016 500
2017 565
2018 550
2019 526
2020 580
2021 347
Text availability
Article attribute
Article type
Publication date

Search Results

6,485 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer.
Perets R, Bar J, Rasco DW, Ahn MJ, Yoh K, Kim DW, Nagrial A, Satouchi M, Lee DH, Spigel DR, Kotasek D, Gutierrez M, Niu J, Siddiqi S, Li X, Cyrus J, Chackerian A, Chain A, Altura RA, Cho BC. Perets R, et al. Among authors: lee dh. Ann Oncol. 2021 Mar;32(3):395-403. doi: 10.1016/j.annonc.2020.11.020. Epub 2020 Dec 2. Ann Oncol. 2021. PMID: 33276076 Free article. Clinical Trial.
Clinical Course and Outcomes of 3,060 Patients with Coronavirus Disease 2019 in Korea, January-May 2020.
Sung HK, Kim JY, Heo J, Seo H, Jang YS, Kim H, Koh BR, Jo N, Oh HS, Baek YM, Park KH, Shon JA, Kim MC, Kim JH, Chang HH, Park Y, Kang YM, Lee DH, Oh DH, Park HJ, Song KH, Lee EK, Jeong H, Lee JY, Ko JY, Choi J, Ryu EH, Chung KH, Oh MD; Korea National Committee for Clinical Management of COVID-19. Sung HK, et al. Among authors: lee dh. J Korean Med Sci. 2020 Aug 3;35(30):e280. doi: 10.3346/jkms.2020.35.e280. J Korean Med Sci. 2020. PMID: 32743995 Free PMC article.
Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non-small Cell Lung Cancer.
Yu HA, Paz-Ares LG, Yang JC, Lee KH, Garrido P, Park K, Kim JH, Lee DH, Mao H, Wijayawardana SR, Gao L, Hozak RR, Chao BH, Planchard D. Yu HA, et al. Among authors: lee dh. Clin Cancer Res. 2021 Feb 15;27(4):992-1002. doi: 10.1158/1078-0432.CCR-20-1690. Epub 2020 Oct 12. Clin Cancer Res. 2021. PMID: 33046516
Cardiovascular Toxicities of Bruton's Tyrosine Kinase Inhibitors.
Pineda-Gayoso R, Alomar M, Lee DH, Fradley MG. Pineda-Gayoso R, et al. Among authors: lee dh. Curr Treat Options Oncol. 2020 Jun 30;21(8):67. doi: 10.1007/s11864-020-00764-6. Curr Treat Options Oncol. 2020. PMID: 32607825 Review.
Saliva Firing from Parotid Ducts.
Lee DH, Lim SC. Lee DH, et al. N Engl J Med. 2020 Oct 22;383(17):e98. doi: 10.1056/NEJMicm1911829. N Engl J Med. 2020. PMID: 33085864 No abstract available.
6,485 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page